These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8255017)
1. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise]. Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017 [TBL] [Abstract][Full Text] [Related]
2. [Effects of inhaled beta-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with pulmonary emphysema]. Igarashi T; Nishimura M; Akiyama Y; Yamamoto M; Kobayashi S; Miyamoto K; Kawakami Y Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):32-6. PubMed ID: 8096880 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease. Koyama H; Nishimura K; Ikeda A; Izumi T Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955 [TBL] [Abstract][Full Text] [Related]
5. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Ikeda A; Nishimura K; Koyama H; Izumi T Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652 [TBL] [Abstract][Full Text] [Related]
6. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763 [TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction. Frith PA; Jenner B; Atkinson J Respiration; 1986; 50 Suppl 2():294-7. PubMed ID: 3563116 [TBL] [Abstract][Full Text] [Related]
8. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug. Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822 [TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease. Teramoto S; Fukuchi Y; Orimo H Chest; 1993 Jun; 103(6):1774-82. PubMed ID: 8404100 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living. Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947 [TBL] [Abstract][Full Text] [Related]
11. [Effects of inhaled oxitropium bromide, an anticholinergic drug, on pulmonary hemodynamics in patients with chronic obstructive pulmonary diseases]. Saito S; Miyamoto K; Aida A; Saito H; Sato F; Tsujino I; Nakano T; Nishimura M; Kawakami Y Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):924-9. PubMed ID: 8538086 [TBL] [Abstract][Full Text] [Related]
12. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722 [TBL] [Abstract][Full Text] [Related]
13. [Effects of oxitropium bromide on exercise and lung function in patients with pulmonary emphysema]. Nakanishi N; Ueda N; Kitade M; Moritaka T; Kamei T Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):38-42. PubMed ID: 9071154 [TBL] [Abstract][Full Text] [Related]
14. [Effects of inhaled anticholinergic agents and beta 2-agonists on distilled water induced cough in patients with chronic cough]. Tanaka S Arerugi; 1996 Jan; 45(1):17-27. PubMed ID: 8851312 [TBL] [Abstract][Full Text] [Related]
15. [The effect of inhaled anticholinergic drug on dyspnea and on the physiologic function of respiratory system in patients with chronic obstructive pulmonary disease]. Teramoto S; Suzuki M; Matsuse T; Ohga E; Katayama H; Fukuchi Y; Ouchi Y Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1209-14. PubMed ID: 9493448 [TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD. Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C Respiration; 2008; 76(1):61-8. PubMed ID: 18319586 [TBL] [Abstract][Full Text] [Related]
17. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD. Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma. Nishi K; Fujimura M; Myou S; Ooka T; Sakamoto S; Saitou M; Kasahara K; Matsuda T Clin Auton Res; 1993 Feb; 3(1):41-4. PubMed ID: 8477180 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease. Teramoto S; Matsuse T; Sudo E; Ohga E; Katayama H; Suzuki M; Ouchi Y; Fukuchi Y Intern Med; 1996 Oct; 35(10):772-8. PubMed ID: 8933184 [TBL] [Abstract][Full Text] [Related]